ABSTRACT Objective: Differentiated thyroid carcinoma (DTC) is the most common endocrine malignancy and usually has a favorable prognosis. However, both diagnostic and prognostic evaluations currently rely mainly on postoperative histopathological results. Systemic inflammation-based indices — such as the Systemic Immune-Inflammation Index (SII), Systemic Inflammation Response Index (SIRI), and Pan-Immune Inflammation Value (PIV) — have recently emerged as potential biomarkers in various cancers. This study aimed to evaluate the diagnostic and prognostic utility of these indices in patients undergoing thyroid surgery. […]
